| 11/17/2020 | BK | Covis Finco restates $954 million credit agreement as AMAG buy closes
|
| 10/1/2020 | BK | Covis to acquire AMAG, $647 million debt obligations
|
| 9/27/2018 | BKCV | S&P lifts, then withdraws AMAG Pharma rating
|
| 6/18/2018 | BKCVHY | S&P puts AMAG on positive watch
|
| 6/15/2018 | BKCVDDEMIGPV | Market Commentary: PHI joins calendar, existing notes gain; MGM dominates; Ardent trades up; AMAG jumps
|
| 2/27/2018 | BKBWHY | AMAG has ‘high degree’ of flexibility, de-levers by 20% during 2017
|
| 2/15/2018 | BKCVDDEMIGPV | Market Commentary: Primary stays quiet, overall market firms; Bombardier up on Q4; funds plunge $6.3 billion
|
| 1/30/2018 | BKCVHY | S&P lowers AMAG, notes
|
| 5/15/2017 | BK | AMAG Pharmaceuticals repays, terminates term loan via convertibles
|
| 5/12/2017 | BKCVHY | Moody’s raises AMAG notes to Ba3
|
| 5/8/2017 | BKCVHY | S&P affirms AMAG, lifts notes to BB-
|
| 2/21/2017 | BKCVHY | Moody’s revises AMAG view to stable
|
| 11/18/2015 | BKBWCVHY | AMAG Pharmaceuticals ends third quarter with $1.1 billion total debt
|
| 8/17/2015 | BK | Market Commentary: Ancestry.com finalizes spread, breaks; Osmose Holdings, JBS USA revisions surface
|
| 8/13/2015 | BKCVDDEMIGPV | Market Commentary: No pricings; Oneok hits road; new Post, AMAG issues firm smartly; funds lose $1.21 billion
|
| 8/13/2015 | BK | Market Commentary: Owens-Brockway Glass, Knowledge Universe, AMAG Pharmaceuticals, Vistage, USI free to trade
|
| 8/12/2015 | BKCVDDEMIGPV | Market Commentary: Post two-part megadeal, upsized AMAG Pharmaceuticals price, AMAG gains; broad market lower
|
| 8/12/2015 | BK | Market Commentary: Global Healthcare breaks; Getty Images declines; Multiple primary deals undergo revisions
|
| 8/12/2015 | BK | AMAG Pharmaceuticals flexes $350 million loan to Libor plus 375 bps
|
| 8/5/2015 | BKCVHY | Moody’s rates AMAG loan Ba2, notes B3
|
| 8/4/2015 | BK | Market Commentary: PODS, Garda break; Pharmaceutical Products, Emdeon revise deals; Graton accelerates deadline
|
| 8/4/2015 | BKCV | S&P lifts AMAG; rates loan BB, notes B+
|
| 8/4/2015 | BK | AMAG Pharmaceuticals launches $350 million loan at Libor plus 400 bps
|
| 7/30/2015 | BK | Market Commentary: Asurion, Hill-Rom, Ardent, PLZ, Mohegan break; Quality Distribution, Linxens revise deals
|
| 7/30/2015 | BK | AMAG Pharmaceuticals to launch $350 million term loan on Tuesday
|
| 6/29/2015 | BKHY | AMAG plans new term loan and bonds for Cord Blood Registry purchase
|
| 11/12/2014 | BK | Market Commentary: AMAG, Panda Stonewall break; SeaWorld drops with earnings; WorldPay revises add-on loan
|
| 11/6/2014 | BK | Market Commentary: Norwegian Cruise Line breaks above OID; AMAG Pharmaceuticals, Essar Steel changes surface
|
| 11/6/2014 | BK | AMAG Pharmaceuticals flexes $340 million loan to Libor plus 625 bps
|
| 10/31/2014 | BKCV | S&P assigns AMAG loan B+
|
| 10/29/2014 | BKCV | Moody’s assigns AMAG CFR B2, loan Ba3
|
| 10/23/2014 | BK | Market Commentary: Hargray Communications breaks; Ocwen, Walter Investment improve; DTZ flexes pricing higher
|
| 10/23/2014 | BK | AMAG Pharmaceuticals launches $340 million loan at Libor plus 550 bps
|
| 10/20/2014 | BK | Market Commentary: Platform Specialty, Arysta move around with acquisition news; Crown Holdings breaks atop OID
|
| 10/20/2014 | BK | AMAG Pharmaceuticals to launch $340 million term loan on Thursday
|
| 9/29/2014 | BK | AMAG Pharmaceuticals to get $340 million term loan for Lumara purchase
|
